Physician

John P. Myers, M.D.

According to 2025 Medicare claims, John Myers, M.D. (NPI: 1881661585) practices ophthalmology in the Pensacola-Ferry Pass-Brent, FL market, with the plurality of this provider's patient population coming from Escambia, FL. This provider's primary affiliated billing organization is SUNIL GUPTA MD LLC (NPI: 1588610075; TIN: 593482386) and primary practice location at 32503-2030.

Myers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,924 traditional Medicare patients, billed 62,986 HCPCS/CPT codes, and received $5,525,949 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,468 prescription claims across 407 beneficiaries totaling $140,839 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 45 records totaling $17,195. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$4.2M$8.4M2015 Medicare payment: $6,459,776 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $6,534,545 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $6,590,314 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $7,077,534 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $7,741,172 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $8,406,583 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $8,282,574 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,050,867 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,461,384 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,525,949 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,32447,212$6,459,776
20162,45846,724$6,534,545
20172,57348,053$6,590,314
20182,60748,605$7,077,534
20192,69249,133$7,741,172
20202,44144,757$8,406,583
20212,41644,115$8,282,574
20222,28838,642$7,050,867
20231,79040,648$5,461,384
20241,92462,986$5,525,949

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$93K$186K2015 Drug cost: $109,364 (USD; Tot_Drug_Cst)2016 Drug cost: $173,629 (USD; Tot_Drug_Cst)2017 Drug cost: $153,122 (USD; Tot_Drug_Cst)2018 Drug cost: $143,664 (USD; Tot_Drug_Cst)2019 Drug cost: $181,592 (USD; Tot_Drug_Cst)2020 Drug cost: $185,745 (USD; Tot_Drug_Cst)2021 Drug cost: $183,195 (USD; Tot_Drug_Cst)2022 Drug cost: $182,379 (USD; Tot_Drug_Cst)2023 Drug cost: $153,171 (USD; Tot_Drug_Cst)2024 Drug cost: $140,839 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152881,063$109,364
20163201,321$173,629
20173301,468$153,122
20183251,362$143,664
20193541,372$181,592
20203511,424$185,745
20213941,449$183,195
20223981,532$182,379
20233711,352$153,171
20244071,468$140,839

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye7413,892$96
92014Established patient complete exam of visual system7823,447$90
92012Established patient problem focused exam of visual system345384$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8111,013$63
92134Imaging of retina1,6934,845$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost654,107$32,437
Prednisolone AcetatePrednisolone Acetate24912,538$14,741
CombiganBrimonidine Tartrate/Timolol301,852$11,674
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol503,684$7,662
ProlensaBromfenac Sodium16933$6,013

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.44$17,195Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$282,044US Retina LLC

FAQ

What Medicare data is available for John P. Myers, M.D.?

Tedicare shows public-source Medicare data for John P. Myers, M.D. (NPI 1881661585), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John P. Myers, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John P. Myers, M.D.?

John P. Myers, M.D. is linked to SUNIL GUPTA MD LLC (billing NPI 1588610075) in the available physician profile data.

Does John P. Myers, M.D. have Open Payments data?

John P. Myers, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.